Delivery Order SPE2DB22D3011-SPE2DB25FQ2GJ
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of OxyContin ER 10 mg tablets (100-count) valued at $3,143.30. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 7, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026....
- The Defense Logistics Agency awarded a $8,292.15 delivery order to AmerisourceBergen Drug Corp for OxyContin ER 40 mg tablets (100-count units) on September 15, 2025, with an ultimate completion date of September 16, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply agreements. The product will be delivered to the company's Conshohocken, Pennsylvania facility, which serves as the prime...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,185.38 to AmerisourceBergen Drug Corp for the supply of OxyContin ER 30 mg tablets (100-count units). The contract, awarded on September 18, 2025, with an ultimate completion date of September 19, 2025, was competitively awarded with no set-aside designation and is structured as a firm fixed-price delivery order. Performance will be executed from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,194.12 on August 14, 2025, for OxyContin ER 30 mg tablets (100-count supply). This firm fixed price, non-set-aside contract is part of AmerisourceBergen's broader engagement with the DLA and represents a delivery order issued under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract specifies performance at AmerisourceBergen's Conshohocken, Pennsylvania...
- The Defense Logistics Agency awarded a delivery order valued at $2,166.03 to AmerisourceBergen Drug Corp for OxyContin ER 30 mg tablets (100-count units) with a firm fixed price and an ultimate completion date of August 25, 2025. This non-set-aside, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through...
- The Defense Logistics Agency awarded a delivery order valued at $1,988.26 to AmerisourceBergen Drug Corp for OxyContin ER 30 mg tablets (100-count units) on August 6, 2025, with an ultimate completion date of August 7, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $1,733.21 to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100-count units) on August 25, 2025, with ultimate completion by August 26, 2025. This is a firm fixed-price delivery order issued under a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement needs across...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of OxyContin ER 10 mg tablets (100-count units) with a ceiling value of $2,098.96. This is a firm fixed price delivery order with an ultimate completion date of August 22, 2025, and represents a non-competitive set-aside contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 30 mg tablets (100-count units) valued at $3,365.72, with a firm fixed price and no set-aside designation. This delivery order, awarded on August 25, 2025, represents a single transaction under AmerisourceBergen's larger contract vehicle with DLA and supports the federal government's pharmaceutical supply chain operations. The vendor, headquartered in Conshohocken, Pennsylvania, is a major...
- The Defense Logistics Agency awarded a $5,001.68 firm fixed-price delivery order to AmerisourceBergen Drug Corp for OxyContin ER 30 mg tablets (100-count units) with an ultimate completion date of August 25, 2025. This non-set-aside contract was awarded competitively on August 22, 2025, with performance to occur at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills this...
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB25FQ2GJDelivery Order
The Defense Logistics Agency (DLA) awarded a $2,142.97 delivery order to AmerisourceBergen Drug Corp for OxyContin ER 30 mg tablets (100-count packages) on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price contract, which received no set-aside designation, was competitively awarded and represents a child delivery order under AmerisourceBergen's larger contract vehicle with DLA. The pharmaceutical will be supplied from the vendor's corporate office located in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. AmerisourceBergen is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's existing portfolio with the DLA includes a comprehensive range of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains, demonstrating its established capability to fulfill federal healthcare procurement requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 8/15/25 |